Compare ALXO & LOAN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ALXO | LOAN |
|---|---|---|
| Founded | 2015 | 1989 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 68.3M | 51.9M |
| IPO Year | 2020 | 1999 |
| Metric | ALXO | LOAN |
|---|---|---|
| Price | $2.08 | $4.35 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 6 | 0 |
| Target Price | ★ $3.42 | N/A |
| AVG Volume (30 Days) | ★ 998.4K | 19.0K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | ★ 10.02% |
| EPS Growth | ★ 31.02 | 2.08 |
| EPS | N/A | ★ 0.35 |
| Revenue | N/A | ★ $9,688,641.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $4.47 |
| P/E Ratio | ★ N/A | $12.52 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.41 | $4.29 |
| 52 Week High | $2.66 | $6.05 |
| Indicator | ALXO | LOAN |
|---|---|---|
| Relative Strength Index (RSI) | 49.66 | 31.16 |
| Support Level | $1.41 | $4.29 |
| Resistance Level | $2.27 | $4.59 |
| Average True Range (ATR) | 0.26 | 0.06 |
| MACD | -0.07 | -0.00 |
| Stochastic Oscillator | 10.77 | 4.87 |
ALX Oncology Holdings Inc is a clinical-stage immuno-oncology company focused on helping patients fight cancer by developing a pipeline of product candidates based on expertise in protein engineering and oncology led by the CD47 blocker, evorpacept, currently in phase 1 and 2 clinical trials. Cancer cells leverage CD47, a cell surface protein, as a don't eat me signal to evade detection by the immune system. The company is developing a next-generation checkpoint inhibitor designed to have a high affinity for CD47 and to avoid the limitations caused by hematologic toxicities inherent in other CD47 blocking approaches.
Manhattan Bridge Capital Inc is a real estate finance company taxed as a REIT that specializes in originating, servicing and managing a portfolio of first mortgage loans. The company offers short-term, secured, non-banking loans which may renew or extend, before or after their initial term expires, to real estate investors to fund their acquisition, renovation, rehabilitation or development of residential or commercial properties located in the New York metropolitan area, including New Jersey and Connecticut, and in Florida.